GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
I

IND Swift Laboratories INDSWFTLAB.NS · INR

Health Care · NSE · 🇮🇳 India

Compare

349.05

+0.24%

Close of 9 Nov 2026, in INR

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in INR, from our data supplier.

FY2026

Revenue

₹6.41bn

FY2017FY2026

Net income

₹414.2m

FY2017FY2026

Free cash flow

−₹1.08bn

FY2017FY2026

Shareholders' equity

₹13.84bn

FY2017FY2026

Income statement

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Revenue₹6.41bn₹5.62bn₹12.81bn₹12.07bn₹10.39bn₹8.91bn₹7.80bn₹7.57bn₹7.65bn₹6.97bn
Research and development—₹23.0m₹355.2m₹425.7m₹327.2m₹330.1m₹59.2m₹5.2m₹300.6m₹1.9m
Operating income₹159.0m₹2.61bn₹2.52bn₹1.79bn₹924.2m₹1.18bn₹731.3m₹1.34bn₹474.2m−₹583.6m
Net income₹414.2m₹2.50bn₹4.21bn₹476.0m−₹21.5m−₹31.5m−₹211.9m₹289.5m₹219.8m−₹391.3m
Diluted earnings per share4.7729.6771.248.06-0.36-0.53-3.586.074.13-4.51

Balance sheet

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Total assets₹16.73bn₹14.38bn₹14.60bn₹18.24bn₹18.01bn₹18.18bn₹18.70bn₹19.24bn₹20.23bn₹21.38bn
Cash and short-term investments₹4.72bn₹4.82bn₹4.94bn₹231.5m₹333.7m₹116.0m₹218.5m₹236.8m₹94.5m₹160.9m
Total liabilities₹2.89bn₹2.65bn₹6.48bn₹11.42bn₹12.00bn₹12.15bn₹12.29bn₹13.36bn₹14.70bn₹16.06bn
Debt₹205.0m₹408.4m₹166.2m₹8.62bn₹9.53bn₹10.05bn₹10.31bn₹11.48bn₹10.83bn₹12.42bn
Shareholders' equity₹13.84bn₹11.73bn₹9.36bn₹6.82bn₹6.01bn₹6.04bn₹6.41bn₹6.04bn₹5.53bn₹5.31bn
Shares outstanding87m84m59m59m59m59m59m48m53m87m

Cash flow

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash from operations−₹198.6m−₹254.7m−₹1.63bn₹1.95bn₹1.50bn₹1.35bn₹1.25bn−₹644.0m₹730.9m₹955.7m
Capital spending−₹877.2m−₹644.1m−₹445.2m−₹127.7m−₹184.1m−₹44.0m−₹111.7m−₹154.3m−₹211.6m−₹321.1m
Free cash flow−₹1.08bn−₹898.8m−₹2.08bn₹1.82bn₹1.32bn₹1.31bn₹1.14bn−₹798.3m₹519.3m₹634.5m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Revenue₹1.91bn₹1.70bn₹1.51bn₹1.53bn₹1.53bn₹5.08bn₹86.6m₹119.6m
Operating income₹256.1m₹124.5m−₹46.6m₹123.6m₹471.1m₹2.60bn−₹147.8m₹10.1m
Net income₹246.8m₹151.1m₹95.4m₹79.9m₹87.7m₹2.49bn₹62,000₹4.1m
Diluted earnings per share2.841.741.130.951.0429.510.000.07
Cash from operations———−₹202.0m—−₹254.0m—−₹233.0m
Capital spending———−₹270.0m—−₹644.0m——
Free cash flow———−₹472.0m—−₹898.0m——
Total assets—₹16.73bn—₹15.44bn—₹14.38bn—₹11.88bn
Cash and short-term investments₹4.42bn₹4.72bn₹4.19bn₹4.33bn₹4.67bn₹4.82bn₹4.38bn₹4.38bn
Debt—₹203.1m—₹220.5m—₹408.4m—₹164.0m
Shareholders' equity₹13.84bn₹13.84bn₹13.07bn₹13.07bn₹11.73bn₹11.73bn₹10.12bn₹10.12bn

Financial ratios

Data as of 3 Oct 2026

FY2026FY2025FY2024FY2023FY2022FY2021FY2020
Operating margin2.5%46.4%19.7%14.8%8.9%13.3%—
Net margin6.5%44.6%32.9%3.9%-0.2%-0.4%—
Return on equity3.0%21.4%45.0%7.0%-0.4%-0.5%—
Return on assets2.5%17.4%28.8%2.6%-0.1%-0.2%—
Free cash flow yield2.0%1.2%-5.1%8.9%7.2%6.0%—
Revenue growth14.2%-56.1%6.1%16.2%16.5%14.3%—
Earnings growth-83.5%-40.5%784.4%-2314.8%-31.7%-85.1%—
Current ratio3.80x3.92x4.43x3.14x3.22x3.00x—
Debt to equity0.01x0.03x0.02x1.26x1.58x1.67x—
Equity ratio82.7%81.6%64.1%37.4%33.4%33.2%—
Interest coverage11.31x89.31x4.93x1.94x0.97x1.18x—
R&D as a share of sales—0.4%2.8%3.5%3.1%3.7%0.8%
Buybacks as a share of market value-2.9%-42.9%-0.1%0.2%0.0%0.1%—

Growth per year

Compound annual rate

3 years5 years10 years
Revenue-19.0%-6.4%-0.2%
Operating income-55.4%-33.1%—
Net income-4.5%——

Average margins

Over each period

1 year3 years5 years10 years
Operating margin23.0%19.2%16.3%11.1%
Net margin24.3%20.6%13.4%7.4%

Valuation history

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Price to earnings75.93.01.512.8-191.1-127.7-17.43.911.8-17.0
Price to sales4.91.30.50.50.40.50.50.10.30.9

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years. Last went ex-dividend on 20 Sept 2011.

FY2012FY2011FY2010FY2009FY2008FY2007FY2006FY2005
Paid in the year1.001.001.001.001.001.501.501.00

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.